Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Internal medicine, Pneumonia, Discontinuation, Lung cancer, and Dexamethasone.
The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: a scoping review
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis
Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non–Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy
Durvalumab after Chemoradiotherapy in Patients with Stage III Non-Small-Cell Lung Cancer: Real-World Outcomes Versus Clinical Trial Results
Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
Development of an international, multidisciplinary, patient-centered Standard Outcome Set for Multiple Sclerosis: The S.O.S.MS project
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia
The risk of community-acquired pneumonia in children using gastric acid suppressants
The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
Chloroquine-induced QTc prolongation in COVID-19 patients
Real‐world treatment patterns and outcomes of patients with extensive disease small cell lung cancer
Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults
Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer
Host-response biomarkers for the diagnosis of bacterial respiratory tract infections
High‐sensitivity cardiac troponin <scp>T</scp> predicts mortality after hospitalization for community‐acquired pneumonia
Trends in prescribing systemic treatment and overall survival for non-small cell lung cancer stage IIIB/IV in the Netherlands: 2008–2012
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts
Health literacy of patients admitted for elective surgery
Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis
Pharmacokinetics of oral <i>vs</i>. intravenous dexamethasone in patients hospitalized with community‐acquired pneumonia
Treatment with anti‐inflammatory drugs in community‐acquired pneumonia